CIK 0001579878
- Non-accelerated filer
- Emerging growth company
Figma, Inc.
Sign in to watch- Ticker
- FIG
- Exchange
- NYSE
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462843087
- Phone
- +1 415-890-5404
- Business address
- 760 MARKET ST., FLOOR 5, SAN FRANCISCO, CA, 94102
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,993,380
- in 12 filings, $10.5M under 10b5-1 plans
Net −$10,993,380. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mulligan Brendan −$9.8M General Counsel and Secretary sold 39% of stake
- Radakovich Lynn Vojvodich −$459K Director sold 19% of stake
- Index Ventures VI (Jersey) LP −$237K 10% owner sold 2% of stake
- Rimer Daniel H. −$237K Director sold 2% of stake
- Herb Tyler −$226K Chief Accounting Officer sold 4% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Field Dylan President & CEO | Conversion · Class B Common Stock 10b5-1 | −62,500 | 14,942,017 | ||
| 2025-11-17 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −3,099 | $37.09 | $115K | 900,839 |
| 2025-11-17 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −1,200 | $37.82 | $45K | 899,639 |
| 2025-11-17 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 | −757 | $38.21 | $29K | 208,789 |
| 2025-11-17 | Field Dylan President & CEO | Conversion 10b5-1 | +3,029,063 | $37.30 | $113.0M | 3,029,063 |
| 2025-11-17 | Field Dylan President & CEO | Sale 10b5-1 | −2,064,640 | $37.04 | $76.5M | 964,423 |
| 2025-11-17 | Field Dylan President & CEO | Sale 10b5-1 | −964,423 | $37.86 | $36.5M | 0 |
| 2025-11-17 | Field Dylan President & CEO | Option exercise · Restricted Stock Units 10b5-1 | −5,625,000 | 5,625,000 | ||
| 2025-11-17 | Field Dylan President & CEO | Option exercise · Class B Common Stock 10b5-1 | +5,625,000 | 40,238,891 | ||
| 2025-11-17 | Field Dylan President & CEO | Conversion · Class B Common Stock 10b5-1 | −3,029,063 | 37,209,828 | ||
| 2025-11-13 | Lilly III John Osborne Director | Other acquisition | +422 | 62,922 | ||
| 2025-11-12 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −10,000 | $45.00 | $450K | 903,181 |
| 2025-11-12 | Rasmussen Kris Chief Technology Officer | Sale 10b5-1 | −31,715 | $45.03 | $1.4M | 11,089,843 |
| 2025-11-12 | Melwani Praveer CFO and Treasurer | Sale 10b5-1 | −10,000 | $45.00 | $450K | 1,612,918 |
| 2025-11-10 | Mulligan Brendan General Counsel and Secretary | Option exercise 10b5-1 | +56,635 | $23.19 | $1.3M | 994,115 |
| 2025-11-10 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −35,549 | $42.94 | $1.5M | 958,566 |
| 2025-11-10 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −36,623 | $43.73 | $1.6M | 921,943 |
| 2025-11-10 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 | −8,762 | $44.51 | $390K | 913,181 |
| 2025-11-10 | Mulligan Brendan General Counsel and Secretary | Option exercise · Stock Option (Right to Buy) 10b5-1 | −56,635 | 0 | ||
| 2025-11-10 | Rasmussen Kris Chief Technology Officer | Option exercise 10b5-1 | +15,428 | $23.19 | $358K | 11,394,347 |
Page 15 of 26 · 510 trades